These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 22912838)

  • 1. Exercise does not protect against MPTP-induced neurotoxicity in BDNF haploinsufficient mice.
    Gerecke KM; Jiao Y; Pagala V; Smeyne RJ
    PLoS One; 2012; 7(8):e43250. PubMed ID: 22912838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exercise protects against MPTP-induced neurotoxicity in mice.
    Gerecke KM; Jiao Y; Pani A; Pagala V; Smeyne RJ
    Brain Res; 2010 Jun; 1341():72-83. PubMed ID: 20116369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methylene blue protects dopaminergic neurons against MPTP-induced neurotoxicity by upregulating brain-derived neurotrophic factor.
    Bhurtel S; Katila N; Neupane S; Srivastav S; Park PH; Choi DY
    Ann N Y Acad Sci; 2018 Nov; 1431(1):58-71. PubMed ID: 29882218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The mesolimbic dopaminergic pathway is more resistant than the nigrostriatal dopaminergic pathway to MPTP and MPP+ toxicity: role of BDNF gene expression.
    Hung HC; Lee EH
    Brain Res Mol Brain Res; 1996 Sep; 41(1-2):14-26. PubMed ID: 8883930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fingolimod (FTY720) is not protective in the subacute MPTP mouse model of Parkinson's disease and does not lead to a sustainable increase of brain-derived neurotrophic factor.
    Komnig D; Dagli TC; Habib P; Zeyen T; Schulz JB; Falkenburger BH
    J Neurochem; 2018 Dec; 147(5):678-691. PubMed ID: 30152864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroprotective effects of madecassoside in early stage of Parkinson's disease induced by MPTP in rats.
    Xu CL; Qu R; Zhang J; Li LF; Ma SP
    Fitoterapia; 2013 Oct; 90():112-8. PubMed ID: 23876367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIF1α is necessary for exercise-induced neuroprotection while HIF2α is needed for dopaminergic neuron survival in the substantia nigra pars compacta.
    Smeyne M; Sladen P; Jiao Y; Dragatsis I; Smeyne RJ
    Neuroscience; 2015 Jun; 295():23-38. PubMed ID: 25796140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Six weeks of voluntary exercise don't protect C57BL/6 mice against neurotoxicity of MPTP and MPP(+).
    Aguiar AS; Tristão FS; Amar M; Chevarin C; Glaser V; de Paula Martins R; Moreira EL; Mongeau R; Lanfumey L; Raisman-Vozari R; Latini A; Prediger RD
    Neurotox Res; 2014 Feb; 25(2):147-52. PubMed ID: 23873578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopaminergic neuroprotective effects of inosine in MPTP-induced parkinsonian mice via brain-derived neurotrophic factor upregulation.
    Khanal S; Bok E; Kim J; Park GH; Choi DY
    Neuropharmacology; 2023 Nov; 238():109652. PubMed ID: 37422180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ropinirole protects against 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP)-induced neurotoxicity in mice via anti-apoptotic mechanism.
    Park G; Park YJ; Yang HO; Oh MS
    Pharmacol Biochem Behav; 2013 Mar; 104():163-8. PubMed ID: 23369986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Running exercise protects the substantia nigra dopaminergic neurons against inflammation-induced degeneration via the activation of BDNF signaling pathway.
    Wu SY; Wang TF; Yu L; Jen CJ; Chuang JI; Wu FS; Wu CW; Kuo YM
    Brain Behav Immun; 2011 Jan; 25(1):135-46. PubMed ID: 20851176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of progesterone administered after MPTP on dopaminergic neurons of male mice.
    Litim N; Morissette M; Di Paolo T
    Neuropharmacology; 2017 May; 117():209-218. PubMed ID: 28192111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic, neurochemical, stereological and neuropathological studies on the potential effects of paraquat in the substantia nigra pars compacta and striatum of male C57BL/6J mice.
    Breckenridge CB; Sturgess NC; Butt M; Wolf JC; Zadory D; Beck M; Mathews JM; Tisdel MO; Minnema D; Travis KZ; Cook AR; Botham PA; Smith LL
    Neurotoxicology; 2013 Jul; 37():1-14. PubMed ID: 23523781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel D3 dopamine receptor-preferring agonist D-264: Evidence of neuroprotective property in Parkinson's disease animal models induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and lactacystin.
    Li C; Biswas S; Li X; Dutta AK; Le W
    J Neurosci Res; 2010 Aug; 88(11):2513-23. PubMed ID: 20623619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroprotection by freshwater clam extract against the neurotoxin MPTP in C57BL/6 mice.
    Hsieh CC; Lin MS; Hua KF; Chen WJ; Lin CC
    Neurosci Lett; 2017 Mar; 642():51-58. PubMed ID: 28126590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of the Effects of MPTP and Paraquat on Dopaminergic Neurons and Microglia in the Substantia Nigra Pars Compacta of C57BL/6 Mice.
    Smeyne RJ; Breckenridge CB; Beck M; Jiao Y; Butt MT; Wolf JC; Zadory D; Minnema DJ; Sturgess NC; Travis KZ; Cook AR; Smith LL; Botham PA
    PLoS One; 2016; 11(10):e0164094. PubMed ID: 27788145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrogen reduces BDNF level, but maintains dopaminergic cell density in the striatum of MPTP mouse model.
    Tripanichkul W; Gerdprasert O; Jaroensuppaperch EO
    Int J Neurosci; 2010 Jul; 120(7):489-95. PubMed ID: 20583901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopamine neuronal protection in the mouse Substantia nigra by GHSR is independent of electric activity.
    Stutz B; Nasrallah C; Nigro M; Curry D; Liu ZW; Gao XB; Elsworth JD; Mintz L; Horvath TL
    Mol Metab; 2019 Jun; 24():120-138. PubMed ID: 30833218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of treadmill exercise on behavioral recovery and neural changes in the substantia nigra and striatum of the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned mouse.
    Smith BA; Goldberg NR; Meshul CK
    Brain Res; 2011 Apr; 1386():70-80. PubMed ID: 21315689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metformin lowers α-synuclein phosphorylation and upregulates neurotrophic factor in the MPTP mouse model of Parkinson's disease.
    Katila N; Bhurtel S; Shadfar S; Srivastav S; Neupane S; Ojha U; Jeong GS; Choi DY
    Neuropharmacology; 2017 Oct; 125():396-407. PubMed ID: 28807678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.